1. Home
  2. EOT vs CDXS Comparison

EOT vs CDXS Comparison

Compare EOT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOT
  • CDXS
  • Stock Information
  • Founded
  • EOT 2009
  • CDXS 2002
  • Country
  • EOT United States
  • CDXS United States
  • Employees
  • EOT N/A
  • CDXS N/A
  • Industry
  • EOT Investment Bankers/Brokers/Service
  • CDXS Major Chemicals
  • Sector
  • EOT Finance
  • CDXS Industrials
  • Exchange
  • EOT Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • EOT 259.4M
  • CDXS 216.6M
  • IPO Year
  • EOT N/A
  • CDXS 2010
  • Fundamental
  • Price
  • EOT $16.73
  • CDXS $2.76
  • Analyst Decision
  • EOT
  • CDXS Buy
  • Analyst Count
  • EOT 0
  • CDXS 2
  • Target Price
  • EOT N/A
  • CDXS $11.00
  • AVG Volume (30 Days)
  • EOT 38.7K
  • CDXS 524.7K
  • Earning Date
  • EOT 01-01-0001
  • CDXS 11-06-2025
  • Dividend Yield
  • EOT 4.51%
  • CDXS N/A
  • EPS Growth
  • EOT N/A
  • CDXS N/A
  • EPS
  • EOT N/A
  • CDXS N/A
  • Revenue
  • EOT N/A
  • CDXS $57,164,000.00
  • Revenue This Year
  • EOT N/A
  • CDXS $12.88
  • Revenue Next Year
  • EOT N/A
  • CDXS $21.64
  • P/E Ratio
  • EOT N/A
  • CDXS N/A
  • Revenue Growth
  • EOT N/A
  • CDXS N/A
  • 52 Week Low
  • EOT $14.63
  • CDXS $1.90
  • 52 Week High
  • EOT $18.30
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • EOT 57.95
  • CDXS 58.86
  • Support Level
  • EOT $16.62
  • CDXS $2.52
  • Resistance Level
  • EOT $16.75
  • CDXS $2.79
  • Average True Range (ATR)
  • EOT 0.15
  • CDXS 0.15
  • MACD
  • EOT 0.00
  • CDXS 0.01
  • Stochastic Oscillator
  • EOT 75.86
  • CDXS 72.65

About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. The company invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: